Literature DB >> 33846131

In Vitro and In Vivo Antifungal Activity of AmBisome Compared to Conventional Amphotericin B and Fluconazole against Candida auris.

Janet Herrada1, Ahmed Gamal1, Lisa Long1, Sonia P Sanchez2, Thomas S McCormick1, Mahmoud A Ghannoum3.   

Abstract

Antifungal activity of AmBisome against Candida auris was determined in vitro and in vivo AmBisome showed MIC50 and MIC90 values of 1 and 2 μg/mL, respectively. Unlike conventional amphotericin B, significant in vivo efficacy was observed in the AmBisome 7.5 mg/kg -treated group in survival and reduction of kidney tissue fungal burden compared to the untreated group. Our data shows that AmBisome shows significant antifungal activity against C. auris in vitro as well as in vivo.
Copyright © 2021 American Society for Microbiology.

Entities:  

Year:  2021        PMID: 33846131     DOI: 10.1128/AAC.00306-21

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  3 in total

1.  An Immunocompromised Mouse Model of Candida auris Systemic Infection.

Authors:  Janet Herrada; Kyle Roberts; Ahmed Gamal; Lisa Long; Mahmoud A Ghannoum
Journal:  Methods Mol Biol       Date:  2022

2.  In Vivo Efficacy of Amphotericin B against Four Candida auris Clades.

Authors:  Lajos Forgács; Andrew M Borman; Renátó Kovács; Dávid Balázsi; Zoltán Tóth; Bence Balázs; Chiu Chun-Ju; Gábor Kardos; Ilona Kovacs; László Majoros
Journal:  J Fungi (Basel)       Date:  2022-05-11

3.  Efficacy of Voriconazole, Isavuconazole, Fluconazole, and Anidulafungin in the Treatment of Emerging Candida auris Using an Immunocompromised Murine Model of Disseminated Candidiasis.

Authors:  Ahmed Gamal; Lisa Long; Janet Herrada; Jalal Aram; Thomas S McCormick; Mahmoud A Ghannoum
Journal:  Antimicrob Agents Chemother       Date:  2021-08-17       Impact factor: 5.191

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.